• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COCHLEAR LTD NUCLEUS ABI541 AUDITORY BRAINSTEM IMPLANT; NUCLEUS AUDITORY BRAINSTEM IMPLANT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COCHLEAR LTD NUCLEUS ABI541 AUDITORY BRAINSTEM IMPLANT; NUCLEUS AUDITORY BRAINSTEM IMPLANT SYSTEM Back to Search Results
Model Number ABI541
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Meningitis (2389)
Event Type  Injury  
Manufacturer Narrative
This report is submitted on september 14, 2017, by cochlear limited on behalf of cochlear americas.(b)(4).
 
Event Description
Per the clinic, the patient experienced an episode of meningitis within 30 days of implantation (specific date not reported).The patient was hospitalised for a period of 1 week and treated with an iv antibiotic.The patient has since recovered and the device remains implanted.The following additional information was received regarding the episode of meningitis.Etiology of deafness - the patient has no history of cochlear malformation or reported craniofacial malformations.The patient did not received pre-implant immunizations.Perioperative antibiotics (ancef and bacitracin irrigation) were administered.The receiver stimulator was not drilled to the dura and no surgical complications were reported.A csf leak occurred post operatively.The meningitis episode occurred within 30 days of a neurologic procedure.No vp shunts or lumbar drains were utilized at the onset of meningitis.Prior to meningitis, there were no signs of inflammation, fluid in the inner ear, middle ear or mastoid cavity.The patient did not have a prior upper respiratory infection or otitis media prior to meningitis.The patient's csf cultures were positive for klebsiella and pcr analysis also showed klebsiella.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NUCLEUS ABI541 AUDITORY BRAINSTEM IMPLANT
Type of Device
NUCLEUS AUDITORY BRAINSTEM IMPLANT SYSTEM
Manufacturer (Section D)
COCHLEAR LTD
1 university avenue
macquarie university, nsw 2109
AS  2109
Manufacturer Contact
sujeewa wijesinghe
1 university avenue
macquarie university, nsw 2109
AS   2109
MDR Report Key6864057
MDR Text Key86078682
Report Number6000034-2017-01693
Device Sequence Number1
Product Code MHE
UDI-Device Identifier09321502020404
UDI-Public(01)09321502020404(11)160504(17)180504
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Audiologist
Type of Report Initial
Report Date 08/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/14/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date05/04/2018
Device Model NumberABI541
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received08/30/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/04/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
-
-